Advertisement

Tema Oncology ETF CANC

Set alert

Price alert · CANC

All alert types
42.29 USD -0.04 -0.09%

At close · Oct 30

42.29 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
42.19 × 6
Ask
42.26 × 6
42.00 Day range 43.07
30.43 52-week range 45.24
YTD
+21.80%
1 year
+37.57%
Open
42.25
Prev close
42.33
Mkt cap
134.36M
Vol
24.93K
Avg vol
24.45K
EPS
1.59
P/E
26.60
Div yield
0.00%
More statistics
Low
42.00
High
43.07
Forward P/E
0.00
Beta
0.00
Short ratio
0.00
Dividend
0.00
Ex-div date
50-d avg
27.30
200-d avg
27.72

2Y chart

Chart tools
Interval

Events in this range
  • Dec 11, 2024Dividend: 0.72827
  • Dec 10, 2025Dividend: 0.0195905
Signals (84)
NameDateAgo
SMA: BullishOct 28, 20263 days ago
MACD: Buy SignalOct 20, 20261 week ago
SMA: BearishSep 23, 20261 month ago
SMA: BullishSep 22, 20261 month ago
SMA: BearishSep 10, 20261 month ago
MACD: Sell SignalAug 28, 20262 months ago
RSI: OverboughtAug 19, 20262 months ago
MACD: Buy SignalAug 7, 20262 months ago
MACD: Sell SignalJul 14, 20263 months ago
RSI: OverboughtJul 9, 20263 months ago
RSI: OverboughtJul 2, 20264 months ago
RSI: OverboughtJun 26, 20264 months ago
SMA: BullishJun 22, 20264 months ago
MACD: Buy SignalJun 15, 20264 months ago
MACD: Sell SignalJun 2, 20265 months ago
SMA: BearishJun 1, 20265 months ago
MACD: Buy SignalMay 22, 20265 months ago
SMA: BullishMay 20, 20265 months ago
SMA: BearishMay 15, 20265 months ago
SMA: BullishMay 4, 20266 months ago
SMA: BearishMay 1, 20266 months ago
SMA: BullishApr 30, 20266 months ago
SMA: BearishApr 29, 20266 months ago
MACD: Sell SignalApr 27, 20266 months ago
RSI: OverboughtApr 17, 20266 months ago
MACD: Buy SignalApr 1, 20267 months ago
SMA: BullishMar 31, 20267 months ago
SMA: BearishMar 17, 20267 months ago
SMA: BullishMar 16, 20267 months ago
SMA: BearishMar 12, 20267 months ago
MACD: Sell SignalMar 3, 20268 months ago
MACD: Buy SignalFeb 23, 20268 months ago
MACD: Sell SignalFeb 20, 20268 months ago
MACD: Buy SignalFeb 19, 20268 months ago
MACD: Sell SignalJan 28, 20269 months ago
MACD: Buy SignalJan 9, 20269 months ago
MACD: Sell SignalDec 3, 202511 months ago
MACD: Buy SignalNov 11, 202511 months ago
RSI: OverboughtNov 11, 202511 months ago
MACD: Sell SignalOct 22, 20251 year ago
RSI: OverboughtOct 20, 20251 year ago
RSI: OverboughtOct 8, 20251 year ago
RSI: OverboughtOct 3, 20251 year ago
MACD: Buy SignalSep 30, 20251 year ago
MACD: Sell SignalSep 16, 20251 year ago
MACD: Buy SignalAug 15, 20251 year ago
SMA: BullishAug 13, 20251 year ago
SMA: BearishAug 7, 20251 year ago
MACD: Sell SignalJul 30, 20251 year ago
MACD: Buy SignalJul 9, 20251 year ago
MACD: Sell SignalJun 18, 20251 year ago
SMA: BullishMay 29, 20251 year ago
SMA: BearishMay 27, 20251 year ago
SMA: BullishMay 23, 20251 year ago
SMA: BearishMay 22, 20251 year ago
MACD: Buy SignalMay 21, 20251 year ago
SMA: BullishMay 20, 20251 year ago
MACD: Sell SignalMay 8, 20251 year ago
SMA: BearishMay 6, 20251 year ago
SMA: BullishApr 28, 20251 year ago
SMA: BearishApr 25, 20251 year ago
SMA: BullishApr 24, 20251 year ago
MACD: Buy SignalApr 16, 20251 year ago
RSI: OversoldApr 4, 20251 year ago
SMA: BearishMar 25, 20251 year ago
MACD: Sell SignalMar 25, 20251 year ago
SMA: BullishMar 24, 20251 year ago
MACD: Buy SignalMar 24, 20251 year ago
SMA: BearishMar 18, 20251 year ago
SMA: BullishMar 17, 20251 year ago
SMA: BearishMar 10, 20251 year ago
SMA: BullishMar 4, 20251 year ago
SMA: BearishMar 3, 20251 year ago
MACD: Sell SignalMar 3, 20251 year ago
MACD: Buy SignalFeb 19, 20251 year ago
SMA: BullishFeb 18, 20251 year ago
MACD: Sell SignalFeb 11, 20251 year ago
SMA: BearishFeb 6, 20251 year ago
SMA: BullishFeb 5, 20251 year ago
SMA: BearishFeb 3, 20251 year ago
SMA: BullishJan 30, 20251 year ago
MACD: Buy SignalJan 3, 20251 year ago
RSI: OversoldDec 18, 20241 year ago
RSI: OversoldDec 13, 20241 year ago

Key statistics

Market cap
0
Enterprise value
0
Trailing P/E
0.00
Forward P/E
0.00
PEG ratio
0.00
Price / sales
0.00
Price / book
0.00
EPS (TTM)
0.00
Beta
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Shares outstanding
0
Short % of float
0.00%
50-day average
27.30
200-day average
27.72

About Tema Oncology ETF

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

News

Your note

Sign in to keep a note on CANC — it syncs with the Stock Master app.

Advertisement